Some authors, described CCN2 as an autocrine regulator of cardiac fibrosis, demonstrating that cardiomyocyte-derived CCN2 is dispensable for cardiac fibrosis, but inhibiting CCN2 induction in activated fibroblasts abrogates the cardiac fibrotic response after angiotensin II infusion [29]. The gene discussed is CCN2; the disease is fibrosis.